You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆生科指彈2.1% 京東健康(06618.HK)彈近11% 惟阿裏巴巴逆市續跌逾3%屢尋底
美國近日經濟數據表現參差,聯儲局官員兼達拉斯聯儲銀行行長卡普蘭指,若Delta變種病毒礙美經濟復甦,他願意調整儘早「收水」看法。納指上週五續彈1.2%跑贏藍籌指數,納指期貨續升近0.4%報15,141。本港恆生科技指數扭兩連挫由紀錄低位反彈高見6,158,現報6,017,回升2.1%。 30只成份股普遍反彈,上週五急跌板塊彈力較強,其中京東健康(06618.HK)扭七連跌,股價由上市低位反彈高見65.5元,現報64.3元,反彈近11%;平安好醫生(01833.HK)、衆安在線(06060.HK)及阿裏健康(00241.HK)回升4.5%-6.3%,後者最強曾高見11.18元。 重磅股騰訊(00700.HK)高見444元遇阻,現報433.8元,僅續彈2%;美團(03690.HK)彈至203.6元無以爲繼,現報195.2元,僅彈0.9%。 金山軟件(03888.HK)、金蝶(00268.HK)、網易(09999.HK)及嗶哩嗶哩(09626.HK)反彈5%-6%。不過,恆指服務公司季檢將藍籌由58只增至60只,9月6日起阿裏巴巴(09988.HK)比重將會下降,該股九連跌屢創上市新低,最低見151.7元,現報152.7元,逆市續跌3.2%。同程藝龍(00780.HK)也跌1.7%報15.34元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account